Hugo Ariel Alvarez

Dr. Hugo Ariel Alvarez

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
NKNadja König
Nadja König
CFChristoph Fiehn
Christoph Fiehn
CWChristine Wolf
Christine Wolf
MSMax Schuster
Max Schuster
ECEmanuel Cura Costa
Emanuel Cura Costa
MLMin Ae Lee-Kirsch
Min Ae Lee-Kirsch
Objectives Familial chilblain lupus is a monogenic form of cutaneous lupus erythematosus caused by loss-of-function mutations in the nucleases TREX1 or SAMHD1. In a family without TREX1 or SAMHD1 mutation, we sought to determine the causative gene and the underlying disease pathology. Methods Exome sequencing was used for disease gene identification. Structural analysis was performed by homology modelling and docking simulations. Type I interferon (IFN) activation was assessed in cells transfected with STING cDNA using an IFN-β reporter and Western blotting. IFN signatures in patient blood in response to tofacitinib treatment were measured by RT-PCR of IFN-stimulated genes. Results In a multigenerational family with five members affected with chilblain lupus, we identified a heterozygous mutation of STING, a signalling molecule in the cytosolic DNA sensing pathway. Structural and functional analyses indicate that mutant STING enhances homodimerisation in the absence of its ligand cGAMP resulting in constitutive type I IFN activation. Treatment of two affected family members with the Janus kinase (JAK) inhibitor tofacitinib led to a marked suppression of the IFN signature. Conclusions A heterozygous gain-of-function mutation in STING can cause familial chilblain lupus. These findings expand the genetic spectrum of type I IFN-dependent disorders and suggest that JAK inhibition may be of therapeutic value.

3 May 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
EHEduardo Howard
Eduardo Howard
ACAlexandra Cousido‐Siah
Alexandra Cousido‐Siah
MLMathieu L. Lepage
Mathieu L. Lepage
JSJérémy P. Schneider
Jérémy P. Schneider
ABAnne Bodlenner
Anne Bodlenner
Philippe CompainPhilippe Compain
Philippe Compain
Multivalent design of glycosidase inhibitors is a promising strategy for the treatment of diseases involving enzymatic hydrolysis of glycosidic bonds in carbohydrates. An essential prerequisite for successful applications is the atomic‐level understanding of how outstanding binding enhancement occurs with multivalent inhibitors. Herein we report the first high‐resolution crystal structures of the Jack bean α‐mannosidase (JBα‐man) in apo and inhibited states. The three‐dimensional structure of JBα‐man in complex with the multimeric cyclopeptoid‐based inhibitor displaying the largest binding enhancements reported so far provides decisive insight into the molecular mechanisms underlying multivalent effects in glycosidase inhibition.

29 June 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDM Florencia Leal Denis
M Florencia Leal Denis
HAHugo Ariel Alvarez
Hugo Ariel Alvarez
NLNatalia Lauri
Natalia Lauri
CACora L Alvarez
Cora L Alvarez
OCOsvaldo Chara
Osvaldo Chara
PSPablo Schwarzbaum
Pablo Schwarzbaum
The peptide mastoparan 7 (MST7) triggered in human erythrocytes (rbcs) the release of ATP and swelling. Since swelling is a well-known inducer of ATP release, and extracellular (ATPe), interacting with P (purinergic) receptors, can affect cell volume (Vr), we explored the dynamic regulation between Vr and ATPe. We made a quantitative assessment of MST7-dependent kinetics of Vr and of [ATPe], both in the absence and presence of blockers of ATP efflux, swelling and P receptors. In rbcs 10 μM MST7 promoted acute, strongly correlated changes in [ATPe] and Vr. Whereas MST7 induced increases of 10% in Vr and 190 nM in [ATPe], blocking swelling in a hyperosmotic medium + MST7 reduced [ATPe] by 40%. Pre-incubation of rbcs with 10 μM of either carbenoxolone or probenecid, two inhibitors of the ATP conduit pannexin 1, reduced [ATPe] by 40–50% and swelling by 40–60%, while in the presence of 80 U/mL apyrase, an ATPe scavenger, cell swelling was prevented. While exposure to 10 μM NF110, a blocker of ATP-P2X receptors mediating sodium influx, reduced [ATPe] by 48%, and swelling by 80%, incubation of cells in sodium free medium reduced swelling by 92%. Results were analyzed by means of a mathematical model where ATPe kinetics and Vr kinetics were mutually regulated. Model dependent fit to experimental data showed that, upon MST7 exposure, ATP efflux required a fast 1960-fold increase of ATP permeability, mediated by two kinetically different conduits, both of which were activated by swelling and inactivated by time. Both experimental and theoretical results suggest that, following MST7 exposure, ATP is released via two conduits, one of which is mediated by pannexin 1. The accumulated ATPe activates P2X receptors, followed by sodium influx, resulting in cell swelling, which in turn further activates ATP release. Thus swelling and P2X receptors constitute essential components of a positive feedback loop underlying ATP-induced ATP release of rbcs.

29 December 2012 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
MOMarcelo Ozu
Marcelo Ozu
HAHugo Ariel Alvarez
Hugo Ariel Alvarez
AMAndrés N. McCarthy
Andrés N. McCarthy
JGJ. Raúl Grigera
J. Raúl Grigera
OCOsvaldo Chara
Osvaldo Chara

28 July 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
MFMaría Elisa Fait
María Elisa Fait
MHMelisa Hermet
Melisa Hermet
FCFrancesc Comelles
Francesc Comelles
PCPere Clapes
Pere Clapes
HAHugo Ariel Alvarez
Hugo Ariel Alvarez
LBLaura Bakás
Laura Bakás
Two novel arginine-based surfactants, Bz-Arg-NHC10 and Bz-Arg-NHC12, were characterized with respect to surface properties and their interaction with human red-blood-cell (HRBC) membranes.

1 June 2020 in Developmental Biology
Verified
Journal Article
Closed access
LMLuis Manuel Muñoz-Nava
Luis Manuel Muñoz-Nava
HAHugo Ariel Alvarez
Hugo Ariel Alvarez
MFMarycruz Flores-Flores
Marycruz Flores-Flores
OCOsvaldo Chara
Osvaldo Chara
MNMarcos Nahmad
Marcos Nahmad